Company Valuation: Clarity Medical Group Holding Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026
Market Cap 1 637.1 496.4 359.1 203.6 190.4
Change - -22.08% -27.66% -43.3% -6.5%
Enterprise Value (EV) 1 416.1 336.2 243.1 80.97 125.7
Change - -19.19% -27.69% -66.69% 55.27%
P/E 36.2x -154x -4.71x -5.94x -4.1x
PBR 2.49x 1.91x 1.89x 1.26x 1.62x
PEG -0.6x 1x -0x 0.1x -0.1x
Capitalization / Revenue 2.83x 2.32x 1.88x 1.13x 1.07x
EV / Revenue 1.85x 1.57x 1.27x 0.45x 0.71x
EV / EBITDA 9.63x -218x -6.03x -3.53x -3.19x
EV / EBIT 11.7x -43.5x -4.32x -2.41x -2.55x
EV / FCF 10.4x -14x -9.17x 3.24x -9.52x
FCF Yield 9.63% -7.12% -10.9% 30.9% -10.5%
Dividend per Share 2 - - - - -
Rate of return - - - - -
EPS 2 0.0346 -0.006108 -0.1444 -0.0648 -0.0865
Distribution rate - - - - -
Net sales 1 225.2 213.8 190.9 180.6 177.8
EBITDA 1 43.19 -1.543 -40.34 -22.91 -39.42
EBIT 1 35.49 -7.722 -56.23 -33.54 -49.26
Net income 1 13.49 -3.191 -75.79 -34.29 -46.41
Net Debt 1 -221.1 -160.2 -116 -122.7 -64.68
Reference price 2 1.2500 0.9400 0.6800 0.3850 0.3550
Nbr of stocks (in thousands) 509,718 528,125 528,125 528,917 536,334
Announcement Date 7/27/22 7/28/23 7/26/24 9/24/26 9/24/26
1HKD in Million2HKD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 24.27M
51.2x4.42x28.72x0.27% 13.27B
19.46x2.3x10.76x0.64% 12.23B
24.45x2.86x9.97x1.65% 10.85B
24.98x2.02x16.3x0.15% 10.19B
77.54x7.67x31.05x - 9.9B
19.45x2.83x11.66x4.12% 9.36B
31.04x1x7.88x1.98% 8.98B
14.26x1.36x7.96x1.88% 8.74B
108.89x13.99x72.94x-.--% 6.78B
Average 41.25x 4.27x 21.92x 1.34% 9.03B
Weighted average by Cap. 39.07x 3.95x 20.36x 1.29%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. 1406 Stock
  4. Valuation Clarity Medical Group Holding Limited